全球医疗保健合约研究组织 (CRO) 市场规模、份额、趋势和成长分析报告（2026-2034 年）

预计医疗保健 CRO（合约研究组织）市场将从 2025 年的 525.6 亿美元成长到 2034 年的 1,013.6 亿美元，2026 年至 2034 年的复合年增长率为 7.57%。

随着製药和生物技术公司越来越多地将研发活动外包，全球医疗保健CRO（合约研究组织）市场正在迅速扩张。 CRO提供广泛的服务，包括临床试验、法规支援、资料管理和实验室检测。透过外包这些活动，公司可以降低营运成本、缩短药物研发週期，并专注于其核心业务。

推动该市场发展的主要因素之一是临床试验和监管要求的日益复杂化。製药公司正与合约研究组织 (CRO) 合作，以充分利用其专业知识、先进技术和全球研究网络。此外，药物研发计画的增加和对创新治疗方法需求的成长也进一步推动了对合约研究服务的需求。

受製药和生技产业持续扩张的推动，医疗保健CRO市场预计未来将保持强劲成长。分散式临床试验、数位资料收集和人工智慧分析等技术进步正在变革研究运作模式。亚太地区的新兴市场凭藉其成本优势和不断提升的临床研究能力，预计将在市场扩张中发挥重要作用。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球医疗保健合约研究组织 (CRO) 市场：按类型划分

• 市场分析、洞察与预测
• 药物发现（标靶检验、先导化合物鑑定、先导化合物优化）
• 临床前
• 临床（I期临床试验服务、II期临床试验服务、III期临床试验服务、IV期临床试验服务）

第五章：全球医疗保健合约研究组织 (CRO) 市场：按服务分类

• 市场分析、洞察与预测
• 计划管理/临床供应管理
• 资料管理
• 法规和医疗事务
• 医用照明
• 临床监测
• 品管/保证
• 生物统计学
• 临床实验主要研究者的补偿
• 检查室
• 受试者招募和临床实验中心
• 科技
• 其他的

第六章：全球医疗保健合约研究组织 (CRO) 市场：按治疗领域划分

• 市场分析、洞察与预测
• 肿瘤学
• 中枢神经系统疾病
• 感染疾病
• 免疫系统疾病
• 心血管疾病
• 呼吸系统疾病
• 糖尿病
• 眼科
• 疼痛管理
• 其他的

第七章 全球医疗保健合约研究组织 (CRO) 市场：按分子分类

• 市场分析、洞察与预测
• 製药

第八章：全球医疗保健合约研究组织 (CRO) 市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • LabCorp
  • Iqvia Inc
  • Thermo Fisher Scientific
  • Icon Plc
  • Syneos Health
  • Charles River Laboratories
  • Parexel International Corporation
  • WuXi AppTec
  • Medpace
  • Sgs Sa
  • Worldwide Clinical Trials
  • Pharmaron GmbH
  • CTI Clinical Trial & Consulting
  • Ergomed
  • GVK Biosciences Private Limited（Aragen）

The Healthcare Contract Research Organization Market size is expected to reach USD 101.36 Billion in 2034 from USD 52.56 Billion (2025) growing at a CAGR of 7.57% during 2026-2034.

The global healthcare contract research organization (CRO) market is expanding rapidly as pharmaceutical and biotechnology companies increasingly outsource research and development activities. CROs provide a wide range of services including clinical trials, regulatory support, data management, and laboratory testing. Outsourcing these activities helps companies reduce operational costs, accelerate drug development timelines, and focus on core competencies.

One of the primary drivers of this market is the growing complexity of clinical trials and regulatory requirements. Pharmaceutical companies are partnering with CROs to access specialized expertise, advanced technologies, and global research networks. Additionally, the increasing number of drug development programs and the rising demand for innovative therapies are further driving the need for contract research services.

Looking forward, the healthcare CRO market is expected to witness strong growth due to the continuous expansion of the pharmaceutical and biotechnology sectors. Technological advancements such as decentralized clinical trials, digital data collection, and artificial intelligence-driven analytics are transforming research operations. Emerging markets in Asia-Pacific are expected to play a key role in market expansion due to cost advantages and growing clinical research capabilities.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Drug Discovery (Target Validation, Lead Identification, Lead Optimization)
• Pre-Clinical
• Clinical (Phase I Trial Services, Phase II Trial Services, Phase III Trial Services, Phase IV Trial Services)

By Service

• Project Management/Clinical Supply Management
• Data Management
• Regulatory/Medical Affairs
• Medical Writing
• Clinical Monitoring
• Quality Management/ Assurance
• Bio-statistics
• Investigator Payments
• Laboratory
• Patient And Site Recruitment
• Technology
• Others

By Therapeutic Area

• Oncology
• CNS Disorders
• Infectious Diseases
• Immunological Disorders
• Cardiovascular Diseases
• Respiratory Diseases
• Diabetes
• Ophthalmology
• Pain Management
• Others

By Molecule

• Pharmaceutical

COMPANIES PROFILED

• LabCorp, Iqvia Inc, Thermo Fisher Scientific, Icon Plc, Syneos Health, Charles River Laboratories, Parexel International Corporation, WuXi AppTec, Medpace, Sgs Sa, Worldwide Clinical Trials, Pharmaron GmbH, CTI Clinical Trial Consulting, Ergomed, GVK Biosciences Private Limited Aragen
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Drug Discovery (Target Validation, Lead Identification, Lead Optimization) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Pre-Clinical Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Clinical (Phase I Trial Services, Phase II Trial Services, Phase III Trial Services, Phase IV Trial Services) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET: BY SERVICE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Service
• 5.2. Project Management/Clinical Supply Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Data Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Regulatory/Medical Affairs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Medical Writing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Clinical Monitoring Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Quality Management/ Assurance Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Bio-statistics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.9. Investigator Payments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.10. Laboratory Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.11. Patient And Site Recruitment Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.12. Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.13. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET: BY THERAPEUTIC AREA 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Therapeutic Area
• 6.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. CNS Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Immunological Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Cardiovascular Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Respiratory Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.8. Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.9. Ophthalmology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.10. Pain Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.11. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET: BY MOLECULE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Molecule
• 7.2. Pharmaceutical Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Type
  • 8.2.2 By Service
  • 8.2.3 By Therapeutic Area
  • 8.2.4 By Molecule
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Type
  • 8.3.2 By Service
  • 8.3.3 By Therapeutic Area
  • 8.3.4 By Molecule
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Type
  • 8.4.2 By Service
  • 8.4.3 By Therapeutic Area
  • 8.4.4 By Molecule
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Type
  • 8.5.2 By Service
  • 8.5.3 By Therapeutic Area
  • 8.5.4 By Molecule
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Type
  • 8.6.2 By Service
  • 8.6.3 By Therapeutic Area
  • 8.6.4 By Molecule
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 LabCorp
  • 10.2.2 Iqvia Inc
  • 10.2.3 Thermo Fisher Scientific
  • 10.2.4 Icon Plc
  • 10.2.5 Syneos Health
  • 10.2.6 Charles River Laboratories
  • 10.2.7 Parexel International Corporation
  • 10.2.8 WuXi AppTec
  • 10.2.9 Medpace
  • 10.2.10 Sgs Sa
  • 10.2.11 Worldwide Clinical Trials
  • 10.2.12 Pharmaron GmbH
  • 10.2.13 CTI Clinical Trial & Consulting
  • 10.2.14 Ergomed
  • 10.2.15 GVK Biosciences Private Limited (Aragen)